{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:22:33Z","timestamp":1648905753546},"reference-count":42,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>O uso cr\u00f4nico de glicocortic\u00f3ides no tratamento de doen\u00e7as sist\u00eamicas causa diminui\u00e7\u00e3o da velocidade de crescimento (VC), podendo acarretar perda estatural final. As intera\u00e7\u00f5es entre o eixo adrenal e o eixo GH-sistema IGF t\u00eam sido descritas, podendo ocorrer em n\u00edvel hipotal\u00e2mico-hipofis\u00e1rio e na regula\u00e7\u00e3o do sistema IGF, inclusive modulando o sinal do IGF-1R. Pode-se dizer que o quadro cl\u00ednico deve ser considerado como estado de defici\u00eancia de Igf-1, absoluta e\/ou funcional. As interven\u00e7\u00f5es que possibilitam a normaliza\u00e7\u00e3o funcional do eixo GH-IGF poderiam reduzir a perda estatural destas crian\u00e7as. Os estudos realizados em pacientes com artrite reumat\u00f3ide juvenil em tratamento com cortic\u00f3ides mostraram acelera\u00e7\u00e3o da VC e diminui\u00e7\u00e3o da perda prot\u00e9ica com o uso de GH recombinante humano (hrGH). A acelera\u00e7\u00e3o da VC foi tamb\u00e9m descrita em pacientes sob corticoterapia cr\u00f4nica por causa da doen\u00e7a intestinal inflamat\u00f3ria ou do transplante renal ap\u00f3s o uso de hrGH. A dose de hrGH guarda correla\u00e7\u00e3o positiva com a acelera\u00e7\u00e3o da VC e os resultados refor\u00e7am que esta defici\u00eancia funcional do eixo GH-IGF pode ser revertida com a administra\u00e7\u00e3o de hrGH. O efeito do hrGH \u00e9 restrito ao per\u00edodo de tratamento e depende do esquema de reposi\u00e7\u00e3o do hrGH, do estado nutricional e das condi\u00e7\u00f5es da doen\u00e7a de base.<\/jats:p>","DOI":"10.1590\/s0004-27302008000500013","type":"journal-article","created":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T14:04:11Z","timestamp":1222697051000},"page":"809-817","source":"Crossref","is-referenced-by-count":0,"title":["Tratamento com hrGH da baixa estatura induzida pelo uso cr\u00f4nico de glicocortic\u00f3ide em crian\u00e7as"],"prefix":"10.1590","volume":"52","author":[{"given":"Carlos Eduardo","family":"Martinelli Jr","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa M. Cunha","family":"Palhares","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","first-page":"183","article-title":"Interactions between glucocorticoids and the growth hormone-insulin-like growth factor axis","volume":"1","author":"Tonshoff B","year":"1997","journal-title":"Pediatr Transplant."},{"key":"ref2","series-title":"Pediatric endocrinology","first-page":"211","volume-title":"Disorders of growth hormone\/insulin-like growth factor secretion and action","author":"Rosenfeld RG","year":"2002","edition":"2"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1152\/ajpendo.00317.2004","article-title":"Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index","volume":"288","author":"van Aken MO","year":"2005","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.1994.tb03792.x","article-title":"Relation between growth hormone and cortisol spontaneous secretion in children","volume":"41","author":"Martinelli CE Jr","year":"1994","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2265.1999.00724.x","article-title":"Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children","volume":"50","author":"Martinelli CE Jr","year":"1999","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref6","series-title":"Influ\u00eancia dos glicocortic\u00f3ides na regula\u00e7\u00e3o do sistema IGF (insulin-like growth factor) em crian\u00e7as e in vitro","author":"Martinelli CE Jr","year":"1996"},{"key":"ref7","series-title":"Neuroendocrinologia b\u00e1sica e aplicada","first-page":"366","volume-title":"Crescimento normal: avalia\u00e7\u00e3o e regula\u00e7\u00e3o end\u00f3crina","author":"Martinelli CE Jr","year":"2005"},{"key":"ref8","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones JI","year":"1995","journal-title":"Endocr Rev."},{"key":"ref9","first-page":"3534","article-title":"Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy","volume":"83","author":"Barreca A","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"ref10","first-page":"2282","article-title":"Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity","volume":"80","author":"Bereket A","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1210\/endo.137.12.8940340","article-title":"Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids","volume":"137","author":"Se\u00f1ar\u00eds RM","year":"1996","journal-title":"Endocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2265.2002.01662.x","article-title":"Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome","volume":"57","author":"Leal-Cerro A","year":"2002","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/eje.1.02329","article-title":"Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease","volume":"156","author":"Pecori Giraldi F","year":"2007","journal-title":"Eur J Endocrinol."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2265.2004.02075.x","article-title":"Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"61","author":"Cunha HM","year":"2004","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref15","first-page":"3059","article-title":"Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate)","volume":"80","author":"Juul A","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.1996.711531.x","article-title":"Serum concentrations of free and total insulin-like growth factor-I, IGF-binding protein-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty","volume":"44","author":"Juul A","year":"1996","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ghir.2007.05.002","article-title":"IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1beta","volume":"17","author":"Macrae VE","year":"2007","journal-title":"Growth Horm IGF Res."},{"key":"ref18","first-page":"24","article-title":"Role of interleukin-6 in growth failure: an animal model","volume":"58","author":"De Benedetti F","year":"2002","journal-title":"Horm Res."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti F","year":"2001","journal-title":"Endocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1096-6374(02)00079-5","article-title":"IL-6 overexpression brings about growth impairment potentially through a GH receptor defect","volume":"12","author":"Lieskovska J","year":"2002","journal-title":"Growth Horm IGF Res."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2265.2005.02244.x","article-title":"Final adult height and body mass index after cure of paediatric Cushing's disease","volume":"62","author":"Davies JH","year":"2005","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1210\/jcem.83.8.5036","article-title":"Treatment of glucocorticoid-induced growth suppression with growth hormone: National Cooperative Growth Study","volume":"83","author":"Allen DB","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","article-title":"Growth hormone increases final height in patients with Juvenile Idiopathic Arthritis: data from a randomized controlled study","volume":"92","author":"Bechtold S","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/S0022-3476(03)00390-1","article-title":"Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study","volume":"143","author":"Bechtold S","year":"2003","journal-title":"J Pediatr."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.1780400218","article-title":"Juvenile rheumatoid arthritis: Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin","volume":"40","author":"Davies UM","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/adc.2004.069138","article-title":"Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia","volume":"91","author":"Grote FK","year":"2006","journal-title":"Arch Dis Child."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s004670050483","article-title":"Effects of growth hormone in short children after renal transplantation: French Society of Pediatric Nephrology","volume":"12","author":"Guest G","year":"1998","journal-title":"Pediatr Nephrol."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3476(97)80023-6","article-title":"Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome","volume":"130","author":"Loke KY","year":"1997","journal-title":"J Pediatr."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/meta.2002.28972","article-title":"Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study","volume":"51","author":"Mauras N","year":"2002","journal-title":"Metabolism."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","article-title":"Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study","volume":"92","author":"Simon D","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"ref31","first-page":"2492","article-title":"Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy","volume":"30","author":"Simon D","year":"2003","journal-title":"J Rheumatol."},{"key":"ref32","first-page":"403","article-title":"Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy: I. Effects on growth velocity and body composition","volume":"83","author":"Touati G","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1210\/jc.2004-1603","article-title":"Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography","volume":"90","author":"Bechtold S","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"ref34","first-page":"1296","article-title":"Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids","volume":"29","author":"Simon D","year":"2002","journal-title":"J Rheumatol."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans","volume":"86","author":"Horber FF","year":"1990","journal-title":"J Clin Invest."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01137966","article-title":"Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts","volume":"13","author":"Jonsson KB","year":"1993","journal-title":"Biosci Rep."},{"key":"ref37","first-page":"869","article-title":"Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect","volume":"80","author":"Mauras N","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/eje.0.1440237","article-title":"IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH","volume":"144","author":"Zhou X","year":"2001","journal-title":"Eur J Endocrinol."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005176-200403000-00007","article-title":"Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease","volume":"38","author":"Bannerjee K","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"ref40","first-page":"117","article-title":"Improving growth in children with inflammatory bowel disease","volume":"68","author":"Ahmed SF","year":"2007","journal-title":"Horm Res."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11102-007-0054-6","article-title":"Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125","volume":"10","author":"Tulipano G","year":"2007","journal-title":"Pituitary","ISSN":"http:\/\/id.crossref.org\/issn\/1386-341X","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/jc.2007-2333","article-title":"Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients","volume":"93","author":"Burt MG","year":"2008","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v52n5\/13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T02:55:48Z","timestamp":1495767348000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302008000500013&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0004-27302008000500013"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302008000500013","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}